Alert

Recommended Alerts

Sign Up For Alerts

Drug Pricing: What Happened in 2019 and What to Watch in 2020

Have you heard that drug prices are too high? If not, you have not been listening to President Donald Trump, Secretary of Health and Human Services (“HHS”) Alex Azar, or almost any member of Congress. In the past year, a dizzying array of drug pricing actions and proposals have come out of the White House and Congress, as well as the governor’s offices and legislative halls in most states.

Read More

CMS Aims to Clarify Medicare Policy on Clinical Trial Coverage


Time to Read: 1 minutes Practices: Health Care, Life Sciences

Printer-Friendly Version

The Centers for Medicare & Medicaid Services has recently launched a number of initiatives addressing Medicare coverage of clinical trial services, including an upcoming "Question & Answer" document on coverage of clinical trial services; proposed revisions to the national coverage decision on clinical trial services; and a revised guidance document for certain national coverage decisions. To learn more about these significant CMS initiatives, click "Download PDF."

Printer-Friendly Version

Cookie Settings